Does LBBAP Differentially Affect Baroreflex Sensitivity and Orthostatic Hypotension Compared with Right Ventricular Septal Pacing?

The one direct signal, and it points the "wrong" way

The most directly relevant data comes from a propensity-matched cohort of de-novo dual-chamber implants. A significant acute drop in systolic blood pressure occurred after implantation overall, from a baseline of roughly 137 mmHg to about 128 mmHg, and the LBBAP group showed a greater systolic reduction than the right ventricular pacing group (approximately Δ11.6 mmHg versus Δ7.6 mmHg). The investigators explicitly hypothesized that pacing influences hemodynamics partly by affecting cardiac autonomic baroreflex function, particularly in less physiological pacing.

The intuitive prediction — that "more physiological" LBBAP should protect against orthostatic hypotension — is not what the acute blood-pressure data show; if anything, LBBAP unloaded systolic pressure more. The likely explanation is restored left ventricular contractile efficiency and altered loading rather than a baroreflex improvement. The practical point is that the directionality one might assume is not established.

What is solid versus what is inferred

What is well-replicated is the upstream mechanics. LBBAP produces a markedly narrower paced QRS and better electromechanical synchrony than both right ventricular apical and right ventricular septal pacing — paced QRS durations around 114 ms for LBBAP versus roughly 148 ms for RV septal pacing, accompanied by lower dyssynchrony indices on speckle-tracking echocardiography. There is also a consistent association between LBBAP and fewer episodes of recurrent unexplained syncope compared with right ventricular pacing.

However, syncope in those cohorts is mostly attributed to hemodynamic and heart-failure pathways and to ventricular pacing burden, not to a measured change in baroreflex gain or sympathovagal indices. It therefore cannot be read as evidence for the autonomic mechanism specifically, and orthostatic-mediated syncope was never isolated as its own endpoint.

Caveat one: the LF/HF ratio is a contested proxy

The frequently repeated assumption that the LF/HF ratio cleanly indexes "sympathovagal balance" has been substantially challenged. Low-frequency power may reflect baroreflex modulation of autonomic outflow rather than sympathetic tone as such, and the LF/HF ratio offers only a single degree of freedom to describe what is fundamentally a two-dimensional autonomic phenomenon. As a result, even a study showing an LF/HF difference between pacing sites would be difficult to interpret as a true sympathovagal shift.

Caveat two: the device governs the chronotropic arm of the reflex

This is the most practically important consideration for orthostatic hypotension specifically. In a pacemaker-dependent or high-burden-paced patient, the heart-rate arm of the baroreflex is partly governed by the device, not by native autonomic traffic. On standing, the reflex tachycardia that normally defends blood pressure is constrained by the programmed lower rate limit and shaped by the rate-response sensor and its slope — regardless of whether ventricular capture is septal or conduction-system based.

In other words, programming (lower rate limit, rate-response configuration, atrioventricular delay) plausibly outweighs any pacing-site effect on orthostatic tolerance. Pacing site changes the vascular and contractile substrate that the baroreflex acts on; the device changes the chronotropic response it can mount. For orthostatic hypotension, the chronotropic arm is usually the larger lever.

Net assessment

A defensible thesis is that LBBAP, by restoring more synchronous contraction, changes ventricular loading and the arterial pressure waveform that baroreceptors sense, which could in principle alter baroreflex set-point and the acute pressure response to positional change — and there is an acute blood-pressure signal consistent with a hemodynamic difference. But the claim that LBBAP "differentially modulates baroreflex sensitivity and sympathovagal balance, thereby altering orthostatic hypotension susceptibility in the elderly" overstates what has actually been measured.

No study has measured baroreflex sensitivity by sequence or spectral methods, or performed tilt-table orthostatic assessment, comparing the two pacing sites in an elderly cohort. This remains a genuinely open, fundable question rather than a settled one, and it is best framed as a hypothesis-generating area of conduction-system-pacing research.